Hongtao Zhang
Hongtao Zhang
Verified email at
Cited by
Cited by
ErbB receptors: from oncogenes to targeted cancer therapies
H Zhang, A Berezov, Q Wang, G Zhang, J Drebin, R Murali, MI Greene
The Journal of clinical investigation 117 (8), 2051-2058, 2007
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
SM Kumar, S Liu, H Lu, H Zhang, PJ Zhang, PA Gimotty, M Guerra, W Guo, ...
Oncogene 31 (47), 4898-4911, 2012
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
Q Wang, H Zhang, K Kajino, MI Greene
Oncogene 17 (15), 1939-1948, 1998
Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo
BW Park, HT Zhang, C Wu, A Berezov, X Zhang, R Dua, Q Wang, G Kao, ...
Nature biotechnology 18 (2), 194-198, 2000
YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14
JM Huang, I Nagatomo, E Suzuki, T Mizuno, T Kumagai, A Berezov, ...
Oncogene 32 (17), 2220-2229, 2013
Advances in clinical immunotherapy for gastric cancer
K Li, A Zhang, X Li, H Zhang, L Zhao
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188615, 2021
Mesothelin, a novel immunotherapy target for triple negative breast cancer
J Tchou, LC Wang, B Selven, H Zhang, J Conejo-Garcia, H Borghaei, ...
Breast cancer research and treatment 133, 799-804, 2012
Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope
Z Zhou, X Du, Z Cai, X Song, H Zhang, T Mizuno, E Suzuki, MR Yee, ...
Journal of Biological Chemistry 287 (8), 5317-5326, 2012
Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: Structure− function analysis
A Berezov, HT Zhang, MI Greene, R Murali
Journal of medicinal chemistry 44 (16), 2565-2574, 2001
BRCA1 and cell signaling
Q Wang, H Zhang, R Fishel, MI Greene
Oncogene 19 (53), 6152-6158, 2000
Disabling receptor ensembles with rationally designed interface peptidomimetics
A Berezov, J Chen, Q Liu, HT Zhang, MI Greene, R Murali
Journal of Biological Chemistry 277 (31), 28330-28339, 2002
Disabling of receptor activator of nuclear factor-κB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo
X Cheng, M Kinosaki, M Takami, Y Choi, H Zhang, R Murali
Journal of Biological Chemistry 279 (8269-8277), 8269-8277, 2004
Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution
HT Zhang, JE Kacharmina, K Miyashiro, MI Greene, J Eberwine
Proceedings of the National Academy of Sciences 98 (10), 5497-5502, 2001
Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function
X Song, B Li, Y Xiao, C Chen, Q Wang, Y Liu, A Berezov, C Xu, Y Gao, ...
Cell reports 1 (6), 665-675, 2012
Targeting cathepsin B for cancer therapies
H Ruan, S Hao, P Young, H Zhang
Horizons in cancer research 56, 23, 2015
Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function
Y Xiao, B Li, Z Zhou, WW Hancock, H Zhang, MI Greene
Current opinion in immunology 22 (5), 583-591, 2010
A sensitive and high-throughput assay to detect low-abundance proteins in serum
H Zhang, X Cheng, M Richter, MI Greene
Nature medicine 12 (4), 473-477, 2006
VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells
H Zhang, Q Wang, K Kajino, MI Greene
DNA and cell biology 19 (5), 253-263, 2000
Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1
Q Wang, H Zhang, S Guerrette, J Chen, A Mazurek, T Wilson, A Slupianek, ...
Oncogene 20 (34), 4640-4649, 2001
Challenges in the clinical utility of the serum test for HER2 ECD
L Lam, N McAndrew, M Yee, T Fu, JC Tchou, H Zhang
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826 (1), 199-208, 2012
The system can't perform the operation now. Try again later.
Articles 1–20